Table 5. The cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in patients≥30 years.
Score | Classification | Cut-offs | Sensitivity, % | Specificity,% | PPV,% | NPV, % |
---|---|---|---|---|---|---|
APRI | Significant fibrosis | 0.4* | 91 | 24 | 42 | 81 |
1.2** | 32 | 90 | 66 | 69 | ||
Cirrhosis | 0.5* | 91 | 36 | 18 | 96 | |
1.5** | 32 | 90 | 33 | 90 | ||
FIB-4 | Significant fibrosis | 0.8* | 90 | 20 | 41 | 77 |
2.1** | 31 | 90 | 66 | 68 | ||
Cirrhosis | 1.2* | 91 | 32 | 17 | 96 | |
2.6** | 35 | 90 | 35 | 90 |
APRI, aspartate transaminase to platelet ratio index; FIB-4, fibrosis index based on the 4 factors; PPV, positive predictive value; NPV, negative predictive value; Cut-offs* were established by obtaining a sensitivity of at least 90%; Cut-offs** were established by obtaining a specificity of at least 90%.